Log In
BCIQ
Print this Print this
 

ST-200

  Manage Alerts
Collapse Summary General Information
Company SiteOne Therapeutics Inc.
DescriptionNav1.7 (SCN9A) subtype selective oral analgesic
Molecular Target Sodium channel ; Nav1.7 (SCN9A)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationPain
Indication DetailsTreat moderate to severe pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today